Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4424)	8/8/2001 10:04:56 AM
From: Icebrg	Read Replies (1) \| Respond to of 52153

Peter, You wrote: >>GZMO (worried about the German kidney vaccine project)>> Can you please elaborate a little on this subject. What is it that worries you. The technology as such or the way the germans go about it. There was some time ago an article about this in the Harvard University Gazette. Some quotes from the article: "Tumors were eliminated in 25 percent of patients with widespread kidney and lethal skin cancers who received a new cancer vaccine. Another 25 percent showed encouraging shrinkage of large and small tumors. Some of the 75 people who have received the vaccine saw their tumors melt away within weeks and remain gone for two to three years to date. No toxic side effects, such as those that plague chemotherapy and radiation, have been reported." and "Amazing results Kufe says he was "impressed and excited" about the results when he visited Göttingen last year. A patient from Switzerland showed up with a large tumor in his lungs and several smaller tumors that had spread from his kidneys. Less than six weeks after vaccination, the main tumor had shrunk to a quarter of its original size and the smaller tumors disappeared. Another patient suffered from kidney cancer that had spread to her brain, an extremely hard situation to treat. It required six vaccinations over six months, but her brain tumor finally went away. Everyone has been "amazed" at the results, Kufe says. He and his colleagues are now trying to repeat the success of the German experiments, a necessary step to obtain approval from the Food and Drug Administration to give the vaccine in the United States. Kufe thinks this can be done in one year. At the same time, he hopes to prove the safety of the vaccine for breast cancer and melanoma." news.harvard.edu This looks very promising to me. What is is that worries you? Ice